Clearside Biomedical, Inc.
NASDAQ:CLSD
0.8491 (USD) • At close May 8, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||
| Net Income
| -34.352 | -32.485 | -32.947 | 0.376 | -18.21 | -30.77 | -82.818 | -58.975 | -25.882 | -17.639 | -10.189 | -7.254 | -3.931 |
| Depreciation & Amortization
| 0.226 | 0.067 | 0.145 | 0.178 | 0.18 | 0.211 | 0.189 | 0.182 | 0.065 | 0.06 | 0.033 | 0.015 | 0.007 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | -0.052 | -0.748 | 0.181 | 0.065 | 0.075 | 0.277 | 0 | 0 |
| Stock Based Compensation
| 4.513 | 4.202 | 4.884 | 5.054 | 3.6 | 4.612 | 4.785 | 3.364 | 1.314 | 0.705 | 0.427 | 0.322 | 0.266 |
| Change In Working Capital
| 0 | 0.72 | 11.236 | -15.343 | 1.122 | -1.299 | -0.874 | 3.954 | 1.29 | 2.741 | 0.228 | 0.072 | 0 |
| Accounts Receivables
| -0.051 | 0 | 10.42 | -10.869 | 1.893 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | -0.681 | -1.262 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -1.433 | 0.614 | 0.694 | 0.681 | -0.631 | -5.582 | -0.314 | 4.715 | 1.424 | 0 | 0 | 0 | 0 |
| Other Working Capital
| 0 | 0.106 | 0.122 | -4.474 | 1.122 | 4.283 | -0.56 | 3.954 | -0.134 | 2.741 | 0.228 | 0.072 | 0 |
| Other Non Cash Items
| 4.915 | 9.361 | 3.317 | -0.998 | 0.188 | 0.23 | 0.266 | 0.211 | 0.439 | 0.156 | 0.1 | 0.006 | 0.748 |
| Operating Cash Flow
| -24.698 | -18.135 | -13.365 | -10.733 | -13.12 | -27.068 | -79.2 | -51.083 | -22.709 | -13.902 | -9.124 | -6.839 | -3.176 |
| Investing Activities: | |||||||||||||
| Investments In Property Plant And Equipment
| 0 | -1.777 | -0.246 | 0 | -0.055 | -0.025 | -0.088 | -0.306 | -0.003 | -0.032 | -0.14 | -0.063 | -0.057 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | -0.66 | -20.121 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -16.911 | 0 | 0 | 0 | 0 | 0 | -80.142 | -48.116 | -54.485 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 17.25 | 0 | 0 | 0 | 0 | 32.95 | 76.47 | 68.543 | 5.708 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| -0.977 | 0 | -0.528 | 0 | -0.055 | 32.95 | 0.66 | 20.121 | -0.36 | 0.004 | 0 | 0 | 0 |
| Investing Cash Flow
| -0.638 | -1.777 | -0.246 | 0 | -0.055 | 32.925 | -3.76 | 20.121 | -49.14 | -0.028 | -0.14 | -0.063 | -0.057 |
| Financing Activities: | |||||||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | -4.349 | -5 | 1.7 | 0 | 1.527 | 5.976 | 2.875 | 0.125 | 0.15 |
| Common Stock Issued
| 16.389 | 1.666 | 0.566 | 23.283 | 11.958 | 13.643 | 79.564 | 5.057 | 84.832 | 12.749 | 0 | 0 | 3.93 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.004 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0.047 | -1.252 | 30.767 | 0.499 | 0.258 | 0.052 | 0.515 | 0.305 | 0.031 | 19.968 | 12.749 | 7.83 | 0 |
| Financing Cash Flow
| 16.436 | 0.414 | 31.333 | 23.782 | 7.867 | 8.695 | 81.779 | 5.362 | 86.39 | 25.944 | 15.624 | 7.955 | 4.076 |
| Other Information: | |||||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -8.9 | -19.498 | 17.722 | 13.049 | -5.308 | 14.552 | -1.181 | -25.6 | 14.541 | 12.014 | 6.36 | 1.053 | 0.843 |
| Cash At End Of Period
| 20.02 | 28.92 | 48.418 | 30.696 | 17.647 | 22.955 | 8.403 | 9.224 | 34.824 | 20.283 | 8.269 | 1.909 | 0.856 |